S. Korea Doctors Cleared To Bypass H1N1 Tests Before Giving Tamiflu
This article was originally published in PharmAsia News
Executive Summary
South Korea's CDC has cleared the nation's physicians to provide Roche's Tamiflu (oseltamivir) without having to conduct infection tests for the H1N1 flu virus. The KCDC also said that despite concerns about the antiviral's side effects, it would provide a list of hospitals and pharmacies where the public can obtain the drug. The KCDC's director said it was aware of the risk and that there is some resistance to Tamiflu, but the agency decided the need to slow the spread of the virus was more important. (Click here for more